InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Tuesday, 03/05/2019 2:20:56 PM

Tuesday, March 05, 2019 2:20:56 PM

Post# of 1237
News: $RTTR Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance

Top-line Data Readout Expected in early Q4 2019 LOS ANGELES, March 05, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut micro...

Read the whole news https://marketwirenews.com/news-releases/ritter-pharmaceuticals-completes-enrollment-in-pivotal-phase-3-clinical-trial-of-rp-g28-in-patients-with-lactose-intolerance-7804850.html